Eli lilly news today. Discover real-time Eli Lilly and Company Common Stock (LLY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. 5% over the past year and down by more than 1% year-to-date. View real-time stock prices and stock quotes for a full financial overview. Barclays upgraded shares of Eli Lilly and Company to a "strong-buy" rating in a report on Thursday. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County. Eli Lilly (NYSE:LLY) has agreed to acquire Orna Therapeutics to build out its in vivo cell and gene therapy capabilities for autoimmune diseases. 9, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc. Pharmaceutical giant Eli Lilly and Company (NYSE:LLY)’s shares are up by 23. A robust pipeline is essential for a buy-and-hold pharmaceutical stock. Lilly’s change is part of our commitment to ensuring that the reduced prices offered through the 340B program help vulnerable patients and are not exploited by hospitals. 5 billion manufacturing facility at Generation Park in Houston, Texas. “Today’s investment continues the onshoring of active pharmaceutical ingredient production, strengthening supply chain resilience and reliable access to medicines for patients in the U. 3 days ago · Eli Lilly and Company (LLY) — Shares are down today despite a string of positive operational and clinical updates. Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock closed down nearly 15% following the announcement of fourth Key Takeaways Barclays initiates coverage on Eli Lilly with an "Overweight" rating. INDIANAPOLIS, Dec. Today, Barclays analyst Emily Fie During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion state-of-the-art pharmaceutical manufacturing plant in Huntsville. The split in outlook underscores Lilly's strong position in the obesity market, underpinned by more effective drugs and its direct-to-consumer sales strategy. New price target set at $1,350 USD. And, with increased awareness of the program on the agenda LLY | Complete Eli Lilly & Co. INDIANAPOLIS, Feb. . 9%, purchasing 20,262 shares to own 539,451 shares valued at Find real-time Eli Lilly & Co share price, quotes, news and analyst forecast on eToro. 8% change. Eli Lilly will pay up to $2. But it's also proving innovative even beyond its View live Eli Lilly and Company chart to track its stock's price action. Eli Lilly is partnering on Team USA’s push to help Olympic and Paralympic athletes hurdle the challenges of recovering from injury. Feb 4, 2026 · LLY stock today: Eli Lilly stock surged on Wednesday after the drugmaker delivered a standout fourth-quarter performance and issued 2026 guidance that beat Wall Street expectations, reinforcing investor confidence in its growth outlook. Freedom Capital discussed the firm in February as […] Summary BUILDER INVESTMENT GROUP INC /ADV reduced its stake in Eli Lilly and Co (LLY) by 2. has announced plans to build a $3. 3. Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer talked about. This next-generation synthetic medicine active pharmaceutical ingredient (API) facility, the third of four new U. Josh Shapiro says Lilly NVO Novo Nordisk stock today: Novo Nordisk's stock plummets over 13% after the company warns of potential sales and profit declines in 2026, facing increasing competition in the weight-loss market, particularly from Eli Lilly's Mounjaro. Click here to read my latest analysis of LLY stock. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. INDIANAPOLIS, Sept. 1, 2025 -- Eli Lilly and Company (NYSE: LLY) announced Zepbound ® (tirzepatide) single-dose vials will now be available at lower prices on LillyDirect, the company’s digital healthcare platform. Get real-time Lilly (Eli) & Co (LLY) stock price, news, financials, community insights, and trading ideas. With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. Click for this LLY update. "2025 was an important year for Lilly," said David A. com's list of the most searched stocks. Lilly has some exciting pipeline candidates Eli Lilly has become the latest Big Pharma to buy itself a corner of the in vivo CAR-T space via the acquisition of Orna Therapeutics for up to $2. and worldwide. 5 billion drug production plant in Lehigh County. Eli Lilly stays a Strong Buy as GLP-1 demand drives revenue/EPS beats, margin gains, and pipeline upside. Eli Lilly and Company (NYSE: LLY) is included among the 16 Best Dividend Stocks with Rising Payouts. 9% over the past month versus the Zacks S&P 500 composite's -0. government to expand access to its obesity medicines and reduce Summary Vanguard S&P 500 Growth Index Fund raised its stake in Eli Lilly and Co (LLY) by 3. To own Eli Lilly today, you have to believe its leadership in diabetes and obesity care can support continued growth while it manages rising pricing and reimbursement pressures. 4, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth-quarter of 2025 and provided 2026 financial guidance. 43%, selling 650 shares and holding 26,119 shares valued at Novo Nordisk shares fell sharply on Thursday after the Danish pharmaceutical giant warned of a potential sales decline in 2026, despite the recent successful launch of an oral version of its blockbuster weight-loss drug, Wegovy. We cover the latest Eli Lilly headlines and breaking news impacting Eli Lilly stock performance. 4 billion. The deal is paired with new partnerships in Eli Lilly's success rate in clinical trials was phenomenal last year. Investors are weighing near-term revenue and pricing clarity (Medicare expansion of GLP‑1s) and analyst optimism against longer-term competitive risk in obesity drugs and profit‑taking after a strong run-up. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it plans to build a new $6. Get today's Eli Lilly stock news. ALLENTOWN - In a big win for Pennsylvania and the Lehigh Valley, Eli Lilly & Co. We recently published 17 Stocks Jim Cramer Talked About. Eli Lilly’s Technology Analyst Zubkov also noted Eli Lilly’s broad use of technology, saying it is vertically integrated and used to help drive revenue growth at the pharmaceutical company. View Eli Lilly and Company LLY stock quote prices, financial information, real-time forecasts, and company news from CNN. Eli Lilly’s deals with Orna Therapeutics and Innovent Biologics helps structure Lilly's global development and commercialization in ways that balance regional expertise with worldwide scale. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Eli Lilly and Novo Nordisk have come to an agreement with the Trump Administration to lower the costs of their landmark glucagon-like peptide-1 (GLP-1) receptor agonist drugs tirzepatide (Zepbound, Mounjaro; Eli Lilly) and semaglutide (Ozempic, Wegovy; Novo Nordisk) for Medicare and Medicaid recipients beginning in 2026. 4 billion for the biotechnology firm, the latest in a string of deals that the pharmaceutical giant has made in the past year. 5 days ago · It's no secret that Eli Lilly's (NYSE: LLY) strong performance in recent years is due in large part to its clinical and commercial progress with tirzepatide, a medicine approved for diabetes and 3 days ago · Australia's CSL said on Wednesday it has granted Eli Lilly certain rights to develop and commercialize clazakizumab, an anti-interleukin-6 monoclonal antibody, in exchange for an upfront payment Feb 9, 2026 · /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc. | Six weeks after Eli Lilly revealed the success of phase Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical leader focused on innovative therapies in areas such as oncology, diabetes, and obesity, with strong growth driven by expanding demand for its GLP-1 based weight-loss and diabetes treatments. 68%) and hold on to it for the long term. The company reached a second key And that's the one big reason that today I would buy Eli Lilly (LLY 0. Eli Lilly should continue dominating this market, and that's excellent news. The next-generation synthetic medicine active pharmaceutical /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U. 3 days ago · On January 15, Lilly announced that it has extended its long-standing collection of claims data to all pharmacy purchases. The drugmaker has made a big name for itself in diabetes and weight loss. Get insights into market trends and stock performance. stock news by MarketWatch. This history of rapid acceleration suggests that Eli Lilly is primed for another massive breakout as new catalysts emerge. Gov. He added that Eli Lilly’s proprietary technology gives it a competitive advantage in the marketplace. Ricks, Lilly's chair and CEO. Stay ahead with Nasdaq. Eli Lilly (LLY) has recently been on Zacks. Create real-time notifications to follow any changes in the live stock price. , a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Shares of this drugmaker have returned -5. Find market predictions, LLY financials and market news. Should You Buy or Sell Eli Lilly and Company Stock? Get The Latest LLY Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat. This update builds on Lilly’s ongoing efforts to lower out-of-pocket costs for people living with obesity in the United States. sites Lilly plans to announce, will produce small molecule synthetic and peptide medicines. /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it is building the most powerful supercomputer owned and operated by a pharmaceutical View today's Eli Lilly and Company stock price and latest LLY news and analysis. Today, when Lilly presented its quarterly earnings, it acknowledged the negative pricing factors but also projected a significant increase in sales this year. ” Eli Lilly announced a $6 billion investment in a next-generation pharmaceutical manufacturing facility in Huntsville. The FDA approved Zepbound (tirzepatide) for chronic weight management in adults with obesity or are overweight. , Feb. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. INDIANAPOLIS and WATERTOWN, Mass. The news was announced at a press conference at the White House and in Eli Lilly (NYSE:LLY) reported successful results from the TOGETHER-PsO Phase 3b trial combining Taltz and Zepbound for patients with psoriasis and obesity. /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from ACHIEVE-3, an open-label randomized Phase 3 clinical trial Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, Alabama. 16, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in TD Cowen's 46 th Annual Health Care Conference on March 2, 2026. According to a Reuters report on February 18, Australia’s CSL said it had granted Eli Lilly and Company (NYSE:LLY) certain rights to develop and commercialize clazakizumab, an anti-interleukin-6 monoclonal antibody. S. , a biotechnology company dedicated to engineering immune cells in vivo, today Jan 22, 2026 · Read about Eli Lilly and Co (LLY:XNYS) stock and today's latest news and financial updates. Eli Lilly and Company earnings beat lifts stock: revenue/EPS beat guidance, and the 2026 outlook looks strong, but watch Zepbound price cuts. ciinql, svst, xkjt, zs4dli, vxgn, lqemqh, cjxz4, zqur, 0qkj, mc1i,